삼성서울병원

Ko En

Obstetrics and Gynecology Kim, Byoung Gie M.D

Expertise
Treament Schedule 05 月
DATE
THU
01
FRI
02
SAT
03
SUN
04
MON
05
TUE
06
WEB
07
THU
08
FRI
09
SAT
10
SUN
11
MON
12
TUE
13
WEB
14
THU
15
FRI
16
SAT
17
SUN
18
MON
19
TUE
20
WEB
21
THU
22
FRI
23
SAT
24
SUN
25
MON
26
TUE
27
WEB
28
THU
29
FRI
30
SAT
31
AM
PM
Treament Schedule 06 月
DATE
SUN
01
MON
02
TUE
03
WEB
04
THU
05
FRI
06
SAT
07
SUN
08
MON
09
TUE
10
WEB
11
THU
12
FRI
13
SAT
14
SUN
15
MON
16
TUE
17
WEB
18
THU
19
FRI
20
SAT
21
SUN
22
MON
23
TUE
24
WEB
25
THU
26
FRI
27
SAT
28
SUN
29
MON
30
AM
PM

Medical Education

Seoul National University College of Medicine

Post-Graduate Training

Fellowship   Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
Seoul National University Hospital
Residency   Seoul National University Hospital
Internship   Seoul National University Hospital

Professional Appointments

Guest researcher National Cancer Institute, Bethesda, MD, USA

Professional Memberships

Active Member of American Association for Cancer Research
Active Member of International Gynecological Cancer Society
Member of Scientific Committee of Korean Cancer Association
Member of Scientific Committee of Korean Society of Gynecologic Oncology and Colposcopy
Active Member of Korean Society of Obstetics and Gynecology

Selected Publications

  • J GYNECOL ONCOL 2025 10.3802/jgo.2025.36.e51 Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80) Lee, JY; Tan, DV; Ray-Coquard, I; Lee, JB; Kim, BG; Van Nieuwenhuysen, E; Huang, RYJ; Tse, KY; González-Martin, A; Scott, C; Hasegawa, K; Wilkinson, K; Yang, EY; Lheureux, S; Kristeleit, R
    View PubMed
  • CANCERS 2024 10.3390/cancers16193422 From the Beginning of the Korean Gynecologic Oncology Group to the Present and Next Steps Min, KJ; Kim, NK; Song, JY; Choi, MC; Lee, SW; Lee, KH; Kim, MK; Kang, SK; Choi, CH; Lee, JW; Lee, EJ; Eom, KY; Kim, SW; Cho, HBY; Lee, SJ; Lim, MC; Bae, J; Yoo, CW; Kim, K; Kim, DY; Lee, CL; Ryu, SY; Jeon, S; Kim, JW; Nam, BH; Kang, SB; Kim, KT; Nam, JH; Kim, BG; Kim, YM; Kim, JH
    View PubMed
  • INT J GYNECOL PATHOL 2024 10.1097/PGP.0000000000001007 Risk Factors Affecting Clinical Outcomes of Low-risk Early-stage Human Papillomavirus-Associated Endocervical Adenocarcinoma Treated by Surgery Alone: Application of Silva Pattern Bae, BK; Bae, H; Cho, WK; Kim, BG; Choi, CH; Kim, TJ; Lee, YY; Lee, JW; Kim, HS; Park, W
    View PubMed
  • ECLINICALMEDICINE 2024 10.1016/j.eclinm.2024.102716 GX-188E DNA vaccine plus pembrolizumab in HPV 16-and/or 18-positive recurrent or advance cervical cancer: a phase 2 trial Lim, MC; Choi, YJ; Hur, SY; Kim, YM; No, JH; Kim, BG; Cho, CH; Kim, SH; Jeong, DH; Lee, JK; Kim, JH; Choi, YJ; Woo, JW; Sung, YC; Park, JS
    View PubMed
  • NEW ENGL J MED 2024 10.1056/NEJMoa2313811 Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer Vergote, I; González-Martin, A; Fujiwara, K; Kalbacher, E; Bagaméri, A; Ghamande, S; Lee, JY; Banerjee, S; Maluf, FC; Lorusso, D; Yonemori, K; Van Nieuwenhuysen, E; Manso, L; Woelber, L; Westermann, A; Covens, A; Hasegawa, K; Kim, BG; Raimondo, M; Bjurberg, M; Cruz, FM; Angelergues, A; Cibula, D; Barraclough, L; Oaknin, A; Gennigens, C; Nicacio, L; Teng, MSL; Whalley, E; Soumaoro, I; Slomovitz, BM
    View PubMed
  • JAMA ONCOL 2024 10.1001/jamaoncol.2024.2145 Bintrafusp Alfa for Recurrent or Metastatic Cervical Cancer After Platinum Failure: A Nonrandomized Controlled Trial Birrer, M; Li, GL; Yunokawa, M; Lee, JY; Kim, BG; Oppermann, CP; Zhou, Q; Nishio, S; Okamoto, A; Wu, XH; Mileshkin, L; Oaknin, A; Ray-Coquard, I; Hasegawa, K; Jehl, G; Vugmeyster, Y; Zhang, S; Bajars, M; Yonemori, K
    View PubMed
  • PLOS ONE 2024 10.1371/journal.pone.0305360 Prediction of final pathology depending on preoperative myometrial invasion and grade assessment in low-risk endometrial cancer patients: A Korean Gynecologic Oncology Group ancillary study Jang, DH; Lee, HG; Lee, B; Kang, S; Kim, JH; Kim, BG; Kim, JW; Kim, MH; Chen, XJ; No, JH; Lee, JM; Kim, JH; Watari, H; Kim, SM; Kim, SH; Seong, SJ; Jeong, DH; Kim, YH
    View PubMed
  • FRONT IMMUNOL 2024 10.3389/fimmu.2024.1371353 Efficacy and safety of BVAC-C in HPV type 16-or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study Choi, CH; Lee, JW; Bae, DS; Kang, ES; Cho, DC; Kim, YM; Kim, K; Kim, JW; Kim, HS; Kim, YT; Lee, JY; Lim, MC; Oh, T; Song, B; Jeon, I; Park, M; Kim, WH; Kang, CY; Kim, BG
    View PubMed
  • GYNECOL ONCOL 2024 10.1016/j.ygyno.2023.12.029 Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial Kim, SI; Joung, JG; Kim, YN; Park, J; Park, E; Kim, JW; Lee, SY; Lee, JB; Kim, S; Choi, CH; Kim, HS; Lim, J; Chung, J; Kim, BG; Lee, JY
    View PubMed
  • J GYNECOL ONCOL 2024 10.3802/jgo.2024.35.e40 Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer Yonemori, K; Fujiwara, K; Hasegawa, K; Yunokawa, M; Ushijima, K; Suzuki, S; Shikama, A; Minobe, S; Usami, T; Kim, JW; Kim, BG; Wang, PH; Chang, TC; Yamamoto, K; Han, SR; McKenzie, J; Orlowski, RJ; Miura, T; Makker, V; Kim, YM
    View PubMed
  • FRONT GENET 2024 10.3389/fgene.2024.1342021 Comparison of RNA-Seq and microarray in the prediction of protein expression and survival prediction Kim, WJ; Choi, BR; Noh, JJ; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Choi, CH
    View PubMed
  • GLAND SURG 2024 10.21037/gs-23-249 Initial experience with the enhanced recovery after surgery (ERAS) protocols in gynecologic surgery at an urban academic tertiary medical center Kim, WJ; Noh, JJ; Bang, YJ; Yang, MY; Kim, JH; Park, CH; Song, HJ; Kim, JM; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Min, JJ; Kim, CS; Hahm, TS; Lee, YY
    View PubMed
  • INT J CANCER 2023 10.1002/ijc.34786 Reply to: Comments on Randomized, two-arm, non-comparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045 Kim, YN; Joung, JG; Park, E; Kim, JW; Lee, JB; Lim, J; Kim, S; Choi, CH; Kim, HS; Chung, J; Kim, BG; Lee, JY
    View PubMed
  • J IMMUNOTHER CANCER 2023 10.1136/jitc-2023-007444 Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D Park, J; Lee, JB; Lim, MC; Kim, BG; Kim, JW; Kim, S; Choi, CH; Kim, HS; Park, SY; Lee, JY; KGOG investigators
    View PubMed
  • NAT COMMUN 2023 10.1038/s41467-023-40829-2 Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4 Kim, YN; Park, B; Kim, JW; Kim, BG; Kim, SW; Kim, HS; Choi, CH; Lim, MC; Ngoi, NYL; Tan, DSP; Lee, JY
    View PubMed
  • INT J MOL SCI 2023 10.3390/ijms241813672 Cross-Activation of Regulatory T Cells by Self Antigens Limits Self-Reactive and Activated CD8+ T Cell Responses Cho, E; Han, S; Eom, HS; Lee, SJ; Han, C; Singh, R; Kim, SH; Park, BM; Kim, BG; Kim, YH; Kwon, BS; Nam, KT; Choi, BK
    View PubMed
  • INT J CANCER 2023 10.1002/ijc.34696 Randomized, two-arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045 Kim, YN; Joung, JG; Park, E; Kim, JW; Lee, JB; Lim, J; Kim, S; Choi, CH; Kim, HS; Chung, JS; Kim, BG; Lee, JY
    View PubMed
  • ANN SURG ONCOL 2023 10.1245/s10434-023-13868-8 ASO Visual Abstract: Comparison of Minimally Invasive and Open Surgery for the Treatment of Endometrial Cancer with a High Risk of Recurrence: A Propensity-Score-Matching Study in Korea and Taiwan Chang, CS; Lai, YL; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Cheng, WF; Chen, YL; Lee, YY
    View PubMed
  • ANN SURG ONCOL 2023 10.1245/s10434-023-13695-x Comparison of Minimally Invasive and Open Surgery for the Treatment of Endometrial Cancer with a High Risk of Recurrence: A Propensity Score Matching Study in Korea and Taiwan Chang, CS; Lai, YL; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Cheng, WF; Chen, YL; Lee, YY
    View PubMed
  • J GYNECOL ONCOL 2023 10.3802/jgo.2023.34.e33 The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organization Tan, D; Fujiwara, N; Fujiwara, K; Beale, P; Kim, JW; Ng, J; Kim, SI; Evans, A; Kim, BG
    View PubMed
  • CANCER MED-US 2023 10.1002/cam4.5612 Stratifying the risk of ovarian cancer incidence by histologic subtypes in the Korean Epithelial Ovarian Cancer Study (Ko-EVE) Sung, S; Hong, Y; Kim, BG; Choi, JY; Kim, JW; Park, SY; Kim, JH; Kim, YM; Lee, JM; Kim, TJ; Park, SK
    View PubMed
  • J CLIN ONCOL 2023 10.1200/JCO.22.01549 Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial DiSilvestro, P; Banerjee, S; Colombo, N; Scambia, G; Kim, BG; Oaknin, A; Friedlander, M; Lisyanskaya, A; Floquet, A; Leary, A; Sonke, GS; Gourley, C; Oza, A; Gonzalez-Martin, A; Aghajanian, C; Bradley, W; Mathews, C; Liu, J; McNamara, J; Lowe, ES; Ah-See, ML; Moore, KN
    View PubMed
  • J GYNECOL ONCOL 2023 10.3802/jgo.2023.34.e3 Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan Chou, HH; Fereday, S; DeFazio, A; Chang, CL; Bowtell, D; Hsu, HC; Traficante, N; Jeong, SY; Cheng, WF; Ariyarantne, D; Tung, T; Rajadhyaksha, V; Lee, WH; Brown, D; Kim, BG
    View PubMed
  • OBSTET GYNECOL SURV 2023 10.1097/OGX.0000000000001120 Overall Survival With Maintenance Olaparib at a 7-Year Follow-up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial DiSilvestro, P; Banerjee, S; Colombo, N; Scambia, G; Kim, BG; Oaknin, A; Friedlander, M; Lisyanskaya, A; Floquet, A; Leary, A; Sonke, GS; Gourley, C; Oza, A; Gonzalez-Martin, A; Aghajanian, C; Bradley, W; Mathews, C; Liu, JY; McNamara, J; Lowe, ES; Ah-See, ML; Moore, KN
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2022.996516 Invisible cervical cancers on MRI: Can the type of histology (SCC versus non-SCC) influence surgical planning? Jeon, J; Park, BK; Lee, JW; Choi, CH; Lee, YY; Kim, TJ; Kim, BG
    View PubMed
  • CLIN CANCER RES 2022 10.1158/1078-0432.CCR-22-1206 Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes Meagher, NS; Gorringe, KL; Wakefield, M; Bolithon, A; Pang, CNI; Chiu, DS; Anglesio, MS; Mallitt, KA; Doherty, JA; Harris, HR; Schildkraut, JM; Berchuck, A; Cushing-Haugen, KL; Chezar, K; Chou, A; Tan, A; Alsop, J; Barlow, E; Beckmann, MW; Boros, J; Bowtell, DDL; Brand, AH; Brenton, JD; Campbell, I; Cheasley, D; Cohen, J; Cybulski, C; Elishaev, E; Erber, R; Farrell, R; Fischer, A; Fu, ZX; Gilks, B; Gill, AJ; Gourley, C; Grube, M; Harnett, PR; Hartmann, A; Hettiaratchi, A; Hogdall, CK; Huzarski, T; Jakubowska, A; Jimenez-Linan, M; Kennedy, CJ; Kim, BG; Kim, JW; Kim, JH; Klett, K; Koziak, JM; Lai, T; Laslavic, A; Lester, J; Leung, Y; Li, N; Liauw, W; Lim, BWX; Linder, A; Lubinski, J; Mahale, S; Mateoiu, C; McInerny, S; Menkiszak, J; Minoo, P; Mittelstadt, S; Morris, D; Orsulic, S; Park, SY; Pearce, CL; Pearson, JV; Pike, MC; Quinn, CM; Mohan, GR; Rao, JY; Riggan, MJ; Ruebner, M; Salfinger, S; Scott, CL; Shah, M; Steed, H; Stewart, CJR; Subramanian, D; Sung, S; Tang, K; Timpson, P; Ward,
    View PubMed
  • J VASC INTERV RADIOL 2022 10.1016/j.jvir.2022.10.009 Arteriovenous Malformation Associated with Intravenous Leiomyomatosis of the Uterus: Characteristic CT Findings and Treatment by Embolization and Surgery Kim, JG; Park, YJ; Do, YS; Kim, BG; Lee, JW; Choi, CH; Kim, HC; Park, KB; Hyun, DH
    View PubMed
  • J GYNECOL ONCOL 2022 10.3802/jgo.2022.33.e71 Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy Cho, WK; Kim, HS; Park, W; Chang, CS; Lee, YY; Choi, CH; Kim, TJ; Lee, JW; Kim, BG
    View PubMed
  • INT J GYNECOL CANCER 2022 10.1136/ijgc-2022-003971 Patterns and risk factors of recurrence in low-risk early-stage cervical adenocarcinoma treated with surgery alone: implications on risk group stratification Bae, BK; Cho, WK; Kim, BG; Choi, CH; Kim, TJ; Lee, YY; Lee, JW; Park, W
    View PubMed
  • CANCERS 2022 10.3390/cancers14163863 The Role of Conization before Radical Hysterectomy in Cervical Cancer including High Risk Factors of Recurrence: Propensity Score Matching Chang, CS; Min, JS; Song, KH; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Lee, YY
    View PubMed
  • J GYNECOL ONCOL 2022 10.3802/jgo.2022.33.e45 Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial Lee, JY; Kim, BG; Kim, JW; Lee, JB; Park, E; Joung, JG; Kim, S; Choi, CH; Kim, HS
    View PubMed
  • GYNECOL ONCOL 2022 10.1016/j.ygyno.2022.03.014 Impact of no residual disease on postoperative computed tomography on survival in patients with optimally debulked advanced high-grade serous ovarian cancer during upfront surgery Lim, H; Shim, JI; Park, SJ; Noh, J; Kim, TM; Lee, M; Choi, CH; Chung, HH; Kim, TJ; Lee, JW; Kim, JW; Kim, BG; Park, NH; Song, YS; Kim, SY; Park, SY; Kim, HS; Lee, YY
    View PubMed
  • CANCERS 2022 10.3390/cancers14092139 Prognostic Significance of HER3 Expression in Patients with Cervical Cancer Chang, CS; Shim, JI; Byeon, SJ; Lee, EJ; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Choi, CH
    View PubMed
  • GYNECOL ONCOL 2022 10.1016/j.ygyno.2022.02.002 Second-line olaparib maintenance therapy is associated with poor response to subsequent chemotherapy in BRCA1/2-mutated epithelial ovarian cancer: A multicentre retrospective study Park, J; Kim, SI; Jeong, SY; Kim, Y; Bookman, MA; Kim, JW; Kim, BG; Lee, JY
    View PubMed
  • TAIWAN J OBSTET GYNE 2022 10.1016/j.tjog.2022.02.024 Clinical outcome of pulmonary lymphangitic carcinomatosis in gynecologic malignancy: A single-institution experience Kim, MS; Jeong, SY; Lee, YY; Choi, CH; Kim, TJ; Kim, BG; Bae, DS; Lee, JW
    View PubMed
  • J GYNECOL ONCOL 2022 10.3802/jgo.2022.33.e12 A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/ NIRVANA-R trial Park, J; Lim, MC; Lee, JK; Jeong, DH; Kim, SI; Choi, MC; Kim, BG; Lee, JY
    View PubMed
  • CANCERS 2022 10.3390/cancers14010224 Utility of 3T MRI in Women with IB1 Cervical Cancer in Determining the Necessity of Less Invasive Surgery Jeong, SY; Park, BK; Choi, CH; Lee, YY; Kim, TJ; Lee, JW; Kim, BG
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.023 Effect of Waiting Time from Pathological Diagnosis to Definitive Concurrent Chemoradiation for Cervical Cancer on Overall Survival Noh, KW; Kim, B; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Cho, WK; Park, W; Lee, YY
    View PubMed
  • EUR J HUM GENET 2022 10.1038/s41431-021-00987-7 Polygenic risk modeling for prediction of epithelial ovarian cancer risk Dareng, EO; Tyrer, JP; Barnes, DR; Jones, MR; Yang, X; Aben, KKH; Adank, MA; Agata, S; Andrulis, IL; Anton-Culver, H; Antonenkova, NN; Aravantinos, G; Arun, BK; Augustinsson, A; Balmana, J; Bandera, EV; Barkardottir, RB; Barrowdale, D; Beckmann, MW; Beeghly-Fadiel, A; Benitez, J; Bermisheva, M; Bernardini, MQ; Bjorge, L; Black, A; Bogdanova, NV; Bonanni, B; Borg, A; Brenton, JD; Budzilowska, A; Butzow, R; Buys, SS; Cai, H; Caligo, MA; Campbell, I; Cannioto, R; Cassingham, H; Chang-Claude, J; Chanock, SJ; Chen, KX; Chiew, YE; Chung, WK; Claes, KBM; Colonna, S; Cook, LS; Couch, FJ; Daly, MB; Dao, F; Davies, E; de la Hoya, M; de Putter, R; Dennis, J; DePersia, A; Devilee, P; Diez, O; Ding, YC; Doherty, JA; Domchek, SM; Dork, T; du Bois, A; Durst, M; Eccles, DM; Eliassen, HA; Engel, C; Evans, GD; Fasching, PA; Flanagan, JM; Fortner, R; Machackova, E; Friedman, E; Ganz, PA; Garber, J; Gensini, F; Giles, GG; Glendon, G; Godwin, AK; Goodman, MT; Greene, MH; Gronwald, J; Group, OS; AOCSGroup;
    View PubMed
  • CANCER RES 2022 10.1158/0008-5472.CAN-21-2023 Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response Kang, HG; Hwangbo, H; Kim, MJ; Kim, S; Lee, EJ; Park, MJ; Kim, JW; Kim, BG; Cho, EH; Chang, S; Lee, JY; Choi, JK
    View PubMed
  • LANCET ONCOL 2021 10.1016/S1470-2045(21)00531-3 Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial Banerjee, S; Moore, KN; Colombo, N; Scambia, G; Kim, BG; Oaknin, A; Friedlander, M; Lisyanskaya, A; Floquet, A; Leary, A; Sonke, GS; Gourley, C; Oza, A; Gonzalez-Martin, A; Aghajanian, C; Bradley, WH; Holmes, E; Lowe, ES; DiSilvestro, P
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.770103 Prognostic Relevance of BRCA1 Expression in Survival of Patients With Cervical Cancer Paik, ES; Chang, CS; Chae, YL; Oh, SY; Byeon, SJ; Kim, CJ; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Choi, CH
    View PubMed
  • CANCER SCI 2021 10.1111/cas.15166 Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer Paik, ES; Heo, EJ; Choi, CH; Kim, JH; Kim, JW; Kim, YM; Park, SY; Lee, JW; Kim, JW; Kim, BG
    View PubMed
  • J GYNECOL ONCOL 2021 10.3802/jgo.2021.32.e72 Significance of serum CA125 level in surgically resected cervical adenocarcinoma with adverse features Kim, N; Park, W; Cho, WK; Bae, DS; Kim, BG; Lee, JW; Choi, CH; Kim, TJ; Lee, YY
    View PubMed
  • CANCER RES TREAT 2021 10.4143/crt.2020.1251 Early Metabolic Response Assessed Using F-18-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer Kim, N; Park, W; Cho, WK; Bae, DS; Kim, BG; Lee, JW; Kim, TJ; Choi, CH; Lee, YY; Cho, YS
    View PubMed
  • TAIWAN J OBSTET GYNE 2021 10.1016/j.tjog.2021.05.029 Single-port access (SPA) laparoscopic myomectomy with uterine artery ligation via a retroperitoneal approach is feasible in women with large uterine leiomyoma Noh, JJ; Kim, J; Paik, ES; Kang, JH; Jeong, SY; Choi, CH; Lee, YY; Lee, JW; Kim, BG; Bae, DS; Kim, TJ
    View PubMed
  • GYNECOL ONCOL 2021 10.1016/j.ygyno.2021.02.009 Metabolic syndrome and persistent cervical human papillomavirus infection Lee1, J; Kim, HS; Kim, K; Bae, DS; Kim, BG; Choi, CH
    View PubMed
  • LANCET ONCOL 2021 10.1016/S1470-2045(21)00098-X Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial Friedlander1, M; Moore, KN; Colombo, N; Scambia, G; Kim, BG; Oaknin, A; Lisyanskaya, A; Sonke, GS; Gourley, C; Banerjee, S; Oza, A; Gonzalez-Martin, A; Aghajanian, C; Bradley, WH; Liu, J; Mathews, C; Selle, F; Lortholary, A; Lowe, ES; Hettle, R; Flood, E; Parkhomenko, E; DiSilvestro, P
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.670214 Minimally-Invasive Versus Abdominal Hysterectomy for Endometrial Carcinoma With Glandular or Stromal Invasion of Cervix Jung1, JH; Noh, JJ; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Lee, YY
    View PubMed
  • J GYNECOL ONCOL 2021 10.3802/jgo.2021.32.e31 A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01) Lee1, YJ; Lim, MC; Kim, BG; Ngoi, NY; Choi, CH; Park, SY; Tan, DSP; Go, YJ; Lee, JY
    View PubMed
  • LANCET ONCOL 2020 Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer interim results of a single-arm, phase 2 trial Youn1, JW; Hur, SY; Woo, JW; Kim, YM; Lim, MC; Park, SY; Seo, SS; No, JH; Kim, BG; Lee, JK; Shin, SJ; Kim, K; Chaney, MF; Choi, YJ; Suh, YS; Park, JS; Sung, YC
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9113471 Prognostic Significance of Tumor Regression Rate during Concurrent Chemoradiotherapy in Locally Advanced Cervix Cancer Analysis by Radiation Phase and Histologic Type Kang1, JH; Cho, WK; Yeo, HJ; Jeong, SY; Noh, JJ; Shim, JI; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Park, W; Choi, CH
    View PubMed
  • CANCERS 2020 10.3390/cancers12113188 Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer A Korean Multi-Center Retrospective Study (KGOG1041) Choi1, MC; Kim, YM; Lee, JW; Lee, YJ; Suh, DH; Lee, SJ; Lee, TS; Lee, M; Park, DC; Kim, MK; Lee, JM; Shim, SH; Jeon, S; Min, KJ; Kim, MK; Kim, BW; Park, JY; Kim, BG; Kim, DY; Kim, MH; Kim, HS; Lee, JY
    View PubMed
  • YONSEI MED J 2020 10.3349/ymj.2020.61.11.935 Survival Effects of Cytoreductive Surgery for Refractory Patients after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer Shin1, W; Noh, JJ; Seo, SS; Kang, S; Choi, CH; Park, SY; Kim, BG; Lim, MC
    View PubMed
  • CURR PROB CANCER 2020 10.1016/j.currproblcancer.2020.100557 Triplet chemotherapy vs doublet chemotherapy plus bevacizumab in metastatic, recurrent, and persistent cervical cancer Choi1, HJ; Lee, YY; Choi, CH; Kim, TJ; Lee, JW; Bae, JH; Bae, DS; Kim, BG
    View PubMed
  • J CLIN ONCOL 2020 10.1200/JCO.20.00799 Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation Subgroup Analysis Findings From the SOLO1 Trial DiSilvestro1, P; Colombo, N; Scambia, G; Kim, BG; Oaknin, A; Friedlander, M; Lisyanskaya, A; Floquet, A; Leary, A; Sonke, GS; Gourley, C; Banerjee, S; Oza, A; Gonzalez-Martin, A; Aghajanian, CA; Bradley, WH; Mathews, CA; Liu, J; Lowe, ES; Bloomfield, R; Moore, KN
    View PubMed
  • PHARMACEUTICS 2020 10.3390/pharmaceutics12100987 Anti-Cancer Activity of As4O6 and its Efficacy in a Series of Patient-Derived Xenografts for Human Cervical Cancer Noh1, JJ; Kim, MS; Cho, YJ; Jeong, SY; Lee, YY; Ryu, JY; Choi, JJ; Bae, I; Wu, Z; Kim, BG; Hwang, JR; Lee, JW
    View PubMed
  • BRIT J CANCER 2020 10.1038/s41416-020-01098-8 A multicentre, randomised, open-label, parallel-group Phase 2b study of belotecan versus topotecan for recurrent ovarian cancer Kim1, HS; Park, SY; Park, CY; Kim, YT; Kim, BJ; Song, YJ; Kim, BG; Kim, YB; Cho, CH; Kim, JH; Song, YS
    View PubMed
  • FRONT ONCOL 2020 10.3389/fonc.2020.583515 Feasibility of Single-Port Access (SPA) Laparoscopy for Large Ovarian Tumor Suspected to Be Borderline Ovarian Tumor Kang1, JH; Noh, JJ; Jeong, SY; Shim, JI; Lee, YY; Choi, CH; Lee, JW; Kim, BG; Bae, DS; Kim, HS; Kim, TJ
    View PubMed
  • EUR J GYNAECOL ONCOL 2020 10.31083/j.ejgo.2020.04.5305 Malignant perivascular epithelioid cell tumor (PEComa) of uterus A case report with literature review Noh1, JJ; Hong, SY; Kim, BG
    View PubMed
  • DIAGNOSTICS 2020 10.3390/diagnostics10080537 Ovarian Gynandroblastoma with a Juvenile Granulosa Cell Tumor Component in a Postmenopausal Woman Hwang1, S; Kim, BG; Song, SY; Kim, HS
    View PubMed
  • GYNECOL ONCOL 2020 10.1016/j.ygyno.2020.02.017 Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer Choi1, CH; Chung, JY; Kang, JH; Paik, ES; Lee, YY; Park, W; Byeon, SJ; Chung, EJ; Kim, BG; Hewitt, SM; Bae, DS
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9041137 Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using cis-eQTL Analysis Kim1, J; Chung, JY; Hwang, JR; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH; Hewitt, SM
    View PubMed
  • CURR PROB CANCER 2020 10.1016/j.currproblcancer.2019.100508 Comparison of CA 125 alone and risk of ovarian malignancy algorithm (ROMA) in patients with adnexal mass: A multicenter study Choi1, HJ; Lee, YY; Sohn, I; Kim, YM; Kim, JW; Kang, S; Kim, BG
    View PubMed
  • Front Oncol 2020 10.3389/fonc.2020.00451 Comparison of Laparoscopy and Laparotomy for Para-Aortic Lymphadenectomy in Women With Presumed Stage I-II High-Risk Endometrial Cancer Paik1, ES; Baek, SH; Kang, JH; Jeong, SY; Kim, MS; Kim, WY; Lee, YY; Choi, CH; Lee, JW; Kim, BG; Bae, DS; Kim, TJ
    View PubMed
  • CANCER RES TREAT 2020 10.4143/crt.2019.328 Pretreatment Lymph Node Metastasis as a Prognostic Significance in Cervical Cancer: Comparison between Disease Status Jeong1, SY; Park, H; Kim, MS; Kang, JH; Paik, ES; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH
    View PubMed
  • OBSTET GYNECOL SURV 2020 Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer Coleman1, RL; Spirtos, NM; Enserro, D; Herzog, TJ; Sabbatini, P; Armstrong, DK; Kim, JW; Park, SY; Kim, BG; Nam, JH; Fujiwara, K; Walker, JL; Casey, AC; Secord, AA; Rubin, S; Chan, JK; DiSilvestro, P; Davidson, SA; Cohn, DE; Tewari, KS; Basen-Engquist, K; Huang, HQ; Brady, MF; Mannel, RS
    View PubMed
  • J MINIM INVAS GYN 2020 10.1016/j.jmig.2019.04.005 In Vivo Comparison of MONOFIX, A Novel Barbed Suture with a Triangular Stopper, with Pre-existing Products in a Porcine Model Kim1, J; Eom, HJ; Shin, H; Jeong, SY; Kim, MS; Yoon, HS; In, CH; Kim, BG; Bae, DS; Lee, JW
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9010147 Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16-or 18-Positive Recurrent Cervical Cancer Choi1, CH; Choi, HJ; Lee, JW; Kang, ES; Cho, D; Park, BK; Kim, YM; Kim, DY; Seo, H; Park, M; Kim, W; Choi, KY; Oh, T; Kang, CY; Kim, BG
    View PubMed
  • GYNECOL ONCOL 2020 10.1016/j.ygyno.2019.11.004 CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer Kim1, J; Cho, YJ; Ryu, JY; Hwang, I; Han, HD; Ahn, HJ; Kim, WY; Cho, H; Chung, JY; Hewitt, SM; Kim, JH; Kim, BG; Bae, DS; Choi, CH; Lee, JW
    View PubMed
  • Asian Pac J Cancer Prev. 2019 Feb 26;20(2):425-435. Cost-Utility of a Two-Dose Human Papillomavirus Vaccination Programme Added to Cervical Cancer Screening Compared with Cervical Cancer Screening Alone in Korea Hyunju Lee1, Sooyoung Hur, Hyeongap Jang, I-Heng Lee, Woo-Yun Sohn, Georges Van Kriekinge, Byoung-Gie Kim
    View PubMed
  • J OVARIAN RES 2019 10.1186/s13048-019-0602-5 Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer Jeong1, SY; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Lee, YY
    View PubMed
  • J CLIN MED 2019 10.3390/jcm8111920 Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with BRCA1/2 Mutation: A Korean Multicenter Study Paik1, ES; Lee, YJ; Lee, JY; Shin, W; Park, SY; Kim, SI; Kim, JW; Choi, CH; Kim, BG
    View PubMed
  • NEW ENGL J MED 2019 10.1056/NEJMoa1902626 Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer Coleman1, RL; Spirtos, NM; Enserro, D; Herzog, TJ; Sabbatini, P; Armstrong, DK; Kim, JW; Park, SY; Kim, BG; Nam, JH; Fujiwara, K; Walker, JL; Casey, AC; Alvarez Secord, A; Rubin, S; Chan, JK; DiSilvestro, P; Davidson, SA; Cohn, DE; Tewari, KS; Basen-Engquist, K; Huang, HQ; Brady, MF; Mannel, RS
    View PubMed
  • J GYNECOL ONCOL 2019 10.3802/jgo.2019.30.e112 A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D Lee1, JY; Kim, JW; Lim, MC; Kim, S; Kim, HS; Choi, CH; Yi, JY; Park, SY; Kim, BG; Nam, EJ; Kim, SW; Eoh, KJ; Lee, YJ; Roh, J; Kim, HM; Rae, DS; Lee, JW; Kim, TJ; Lee, YY; Choi, EH; Song, S; Kim, HS; Lee, M; Kim, SI; Lee, EJ; Kwon, SI; Shin, W; Seo, SS; Kang, S; Kim, MS; Kim, JS; Joung, J; Chung, J
    View PubMed
  • SCI REP-UK 2019 10.1038/s41598-019-51959-3 Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer Lee1, YY; Cho, YJ; Shin, SW; Choi, C; Ryu, JY; Jeon, HK; Choi, JJ; Hwang, JR; Choi, CH; Kim, TJ; Kim, BG; Bae, DS; Park, W; Lee, JW
    View PubMed
  • JPN J CLIN ONCOL 2019 10.1093/jjco/hyz085 An umbrella study of biomarker-driven targeted therapy in patients with platinum-resistant recurrent ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3045), AMBITION Lee1, JY; Yi, JY; Kim, HS; Lim, J; Kim, S; Nam, BH; Kim, HS; Kim, JW; Choi, CH; Kim, BG
    View PubMed
  • PLOS MED 2019 10.1371/journal.pmed.1002893 Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis Yarmolinsky1, J; Relton, CL; Lophatananon, A; Muir, K; Menon, U; Gentry-Maharaj, A; Walther, A; Zheng, J; Fasching, P; Zheng, W; Ling, WY; Park, SK; Kim, BG; Choi, JY; Park, B; Smith, GD; Martin, RM; Lewis, SJ
    View PubMed
  • J GYNECOL ONCOL 2019 10.3802/jgo.2019.30.e65 Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods Paik1, ES; Lee, JW; Park, JY; Kim, JH; Kim, M; Kim, TJ; Choi, CH; Kim, BG; Bae, DS; Seo, SW
    View PubMed
  • GYNECOL ONCOL 2019 10.1016/j.ygyno.2019.02.023 Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women Lawrenson1, K; Song, FJ; Hazelett, DJ; Kar, SP; Tyrer, J; Phelan, CM; Corona, RI; Rodriguez-Malave, NI; Seo, JH; Adler, E; Coetzee, SG; Segato, F; Fonseca, MAS; Amos, CI; Carney, ME; Chenevix-Trench, G; Choi, J; Doherty, JA; Jia, WH; Jin, GJ; Kim, BG; Le, ND; Lee, J; Li, L; Lim, BK; Adenan, NA; Mizuno, M; Park, B; Pearce, CL; Shan, K; Shi, YY; Shu, XO; Sieh, W; Thompson, PJ; Wilkens, LR; Wei, QY; Woo, YL; Yan, L; Karlan, BY; Freedman, ML; Noushmehr, H; Goode, EL; Berchuck, A; Sellers, TA; Teo, SH; Zheng, W; Matsuo, K; Park, S; Chen, KX; Pharoah, PDP; Gayther, SA; Goodman, MT
    View PubMed
  • J GYNECOL ONCOL 2019 10.3802/jgo.2019.30.e11 Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff? Kim1, J; Chang, Y; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH
    View PubMed
  • Obstet Gynecol Sci. 2018 May;61(3):352-358. doi: 10.5468/ogs.2018.61.3.352. Epub 2018 May 9. Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer Wonkyo Shin1, Hye-joo Lee, Seong J. Yang, E sun Paik, Hyun-jin Choi, Tae-Joong Kim, Chel Hun Choi, Jeong-Won Lee, Duk-Soo Bae, Byoung-Gie Kim
    View PubMed
  • Obstet Gynecol Sci. 2018 Jul;61(4):524-528. doi: 10.5468/ogs.2018.61.4.524. Epub 2018 Jul 5. Primary malignant melanoma of the uterine cervix treated with pembrolizumab after radical surgery: a case report and literature review Myeong Seon Kim11, Chel-Hun Choi1, Tae-Joong Kim1, Jeong-Won Lee1, Jeeyun Lee2, Duk-Soo Bae1, Byoung-Gie Kim1
    View PubMed
  • Obstet Gynecol Sci. 2018 May;61(3):319-327. doi: 10.5468/ogs.2018.61.3.319. Epub 2018 Apr 27. Clinical characteristics and outcomes of placental site trophoblastic tumor: experience of single institution in Korea Hye-joo Lee1, Wonkyo Shin, Yun Jeong Jang, Chel Hun Choi, Jeong-Won Lee, Duk-Soo Bae, Byoung-Gie Kim
    View PubMed
  • NEW ENGL J MED 2018 10.1056/NEJMoa1810858 Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer Moore1, K; Colombo, N; Scambia, G; Kim, BG; Oaknin, A; Friedlander, M; Lisyanskaya, A; Floquet, A; Leary, A; Sonke, GS; Gourley, C; Banerjee, S; Oza, A; Gonzalez-Martin, A; Aghajanian, C; Bradley, W; Mathews, C; Liu, J; Lowe, ES; Bloomfield, R; DiSilvestro, P
    View PubMed
  • EUR J OBSTET GYN R B 2018 10.1016/j.ejogrb.2018.06.034 The role of appendectomy in patients with mucinous borderline ovarian tumors Song1, T; Kim, MK; Jung, YW; Yun, BS; Seong, SJ; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS
    View PubMed
  • Front Oncol 2018 10.3389/fonc.2018.00465 Genomic Network-Based Analysis Reveals Pancreatic Adenocarcinoma Up-Regulating Factor-Related Prognostic Markers in Cervical Carcinoma Kim1, J; Chung, JY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH; Hewitt, SM
    View PubMed
  • INT J GYNECOL CANCER 2018 10.1097/IGC.0000000000001316 Response to Combination Chemotherapy With Paclitaxel/Ifosfamide/Platinum Versus Paclitaxel/Platinum for Patients With Metastatic, Recurrent, or Persistent Carcinoma of the Uterine Cervix A Retrospective Analysis Choi1, HJ; Paik, ES; Choi, CH; Kim, TJ; Lee, YY; Lee, JW; Bae, DS; Kim, BG
    View PubMed
  • BRIT J CANCER 2018 10.1038/s41416-018-0206-7 Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer Aoki1, Y; Ochiai, K; Lim, S; Aoki, D; Kamiura, S; Lin, H; Katsumata, N; Cha, SD; Kim, JH; Kim, BG; Hirashima, Y; Fujiwara, K; Kim, YT; Kim, SM; Chung, HH; Chang, TC; Kamura, T; Takizawa, K; Takeuchi, M; Kang, SB
    View PubMed
  • J INFECT DIS 2018 10.1093/infdis/jiy133 Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries Garland1, SM; Pitisuttithum, P; Ngan, HYS; Cho, CH; Lee, CY; Chen, CA; Yang, YC; Chu, TY; Twu, NF; Samakoses, R; Takeuchi, Y; Cheung, TH; Kim, SC; Huang, LM; Kim, BG; Kim, YT; Kim, KH; Song, YS; Lalwani, S; Kang, JH; Sakamoto, M; Ryu, HS; Bhatla, N; Yoshikawa, H; Ellison, MC; Han, SR; Moeller, E; Murata, S; Ritter, M; Sawata, M; Shields, C; Walia, A; Perez, G; Luxembourg, A
    View PubMed
  • CANCER RES TREAT 2018 10.4143/crt.2017.104 Molecular Signature for Lymphatic Invasion Associated with Survival of Epithelial Ovarian Cancer Paik1, ES; Choi, HJ; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH
    View PubMed
  • J GYNECOL ONCOL 2018 10.3802/jgo.2018.29.e18 Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis Paik1, ES; Kim, TJ; Choi, CH; Kim, BG; Bae, DS; Lee, JW
    View PubMed
  • CANCER RES TREAT 2018 10.4143/crt.2016.376 An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021) Lee1, SW; Kim, YM; Cho, CH; Kim, YT; Kim, SM; Hur, SY; Kim, JH; Kim, BG; Kim, SC; Ryu, HS; Kang, SB
    View PubMed
  • INT J GYNECOL CANCER 2018 10.1097/IGC.0000000000000602 Pazopanib Maintenance Therapy in East Asian Women With Advanced Epithelial Ovarian Cancer: Results From AGO-OVAR16 and an East Asian Study Kim1, JW; Mahner, S; Wu, LY; Shoji, T; Kim, BG; Zhu, JQ; Takano, T; Park, SY; Kong, BH; Wu, Q; Wang, KL; Ngan, HYS; Liu, JH; Wei, LH; Mitrica, I; Zhang, PK; Crescenzo, R; Wang, Q; Cox, CJ; Harter, P; du Bois, A
    View PubMed
  • J GYNECOL ONCOL 2018 10.3802/jgo.2018.29.e13 Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer Paik1, ES; Kim, JH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH
    View PubMed
  • GYNECOL OBSTET INVES 2018 10.1159/000475817 Elevated Preoperative CA125 or CA19-9 in Borderline Ovarian Tumors: Could It Be Suggestive of Advanced Stage or a Poor Prognosis? Song1, T; Lee, DH; Jung, YW; Yun, BS; Seong, SJ; Choi, CH; Lee, JW; Bae, DS; Kim, BG
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.322 Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies Heo1, EJ; Cho, YJ; Cho, WC; Hong, JE; Jeon, HK; Oh, DY; Choi, YL; Song, SY; Choi, JJ; Bae, DS; Lee, YY; Choi, CH; Kim, TJ; Park, WY; Kim, BG; Lee, JW
    View PubMed
  • EUR RADIOL 2017 10.1007/s00330-017-4765-4 Preservation of the endometrial enhancement after magnetic resonance imaging-guided high-intensity focused ultrasound ablation of submucosal uterine fibroids Kim1, YS; Kim, TJ; Lim, HK; Rhim, H; Jung, SH; Ahn, JH; Lee, JW; Kim, BG
    View PubMed
  • J GYNECOL ONCOL 2017 10.3802/jgo.2017.28.e54 Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference Jang1, JYA; Yanaihara, N; Pujade-Lauraine, E; Mikami, Y; Oda, K; Bookman, M; Ledermann, J; Shimada, M; Kiyokawa, T; Kim, BG; Matsumura, N; Kaku, T; Kuroda, T; Nagayoshi, Y; Kawabata, A; Iida, Y; Kim, JW; Quinn, M; Okamoto, A
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.034 Proton. Pump Inhibition Enhances the Cytotoxicity of Paclitaxel in Cervical Cancer Song1, T; Jeon, HK; Hong, JE; Choi, JJ; Kim, TJ; Choi, CH; Bae, DS; Kim, BG; Lee, JW
    View PubMed
  • SCI REP-UK 2017 10.1038/s41598-017-06510-7 The anti-cancer effects of itraconazole in epithelial ovarian cancer Choi1, CH; Ryu, JY; Cho, YJ; Jeon, HK; Choi, JJ; Ylaya, K; Lee, YY; Kim, TJ; Chung, JY; Hewitt, SM; Kim, BG; Bae, DS; Lee, JW
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.282 Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer Paik1, ES; Sohn, I; Baek, SY; Shim, M; Choi, HJ; Kim, TJ; Choi, CH; Lee, JW; Kim, BG; Lee, YY; Bae, DS
    View PubMed
  • Int J Gynecol Cancer. 2017 Mar;27(3):507-513. doi: 10.1097/IGC.0000000000000909. Parametrial Involvement on Magnetic Resonance Imaging Has No Effect on the Survival of Early-Stage Cervical Cancer Patients Yang K11, Park W, Huh SJ, Park BK, Kim CK, Kim BG, Bae DS, Lee JW.
    View PubMed
  • Sci Rep. 2016 Dec 5;6:38502. doi: 10.1038/srep38502. c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma Kim HJ11, Yoon A2, Ryu JY2, Cho YJ2, Choi JJ2, Song SY3, Bang H3, Lee JS4, Cho WC5, Choi CH2, Lee JW2,6,7, Kim BG2, Bae DS2.
    View PubMed
  • Cancer Biomark. 2016;17(4):419-425. doi: 10.3233/CBM-160658. Preoperative multiplication of neutrophil and monocyte counts as a prognostic factor in epithelial ovarian cancer Paik ES1, Shim M, Choi HJ, Lee YY, Kim TJ, Choi CH, Lee JW, Kim BG, Bae DS.
    View PubMed
  • Anticancer Res. 2016 Dec;36(12):6381-6388. Dynamin 2 Inhibitors as Novel Therapeutic Agents Against Cervical Cancer Cells Lee YY11, Jeon HK2, Lee J3, Hong JE2, Do IG4, Choi CH2, Kim TJ2, Kim BG2, Bae DS2, Kim YC3, Lee JW5.
    View PubMed
  • J Korean Med Sci. 2016 Dec;31(12):1969-1975. doi: 10.3346/jkms.2016.31.12.1969. Development and Validation of the Korean Version of Hand-Foot Skin Reaction and Quality of Life Questionnaire (HF-QoL-K) Nam SH11, Choi HJ2, Kang WD3, Kim SM3, Lim MC4, Park SY4, Kim JS5, Kim BG2, Bae DS2, Lee JW2, Kim TJ2, Song T6.
    View PubMed
  • Obstet Gynecol. 2016 Dec;128(6):1258-1264. Regeneration Process After Cervical Conization for Cervical Intraepithelial Neoplasia Song T11, Seong SJ, Kim BG.
    View PubMed
  • Aust N Z J Obstet Gynaecol. 2016 Dec;56(6):639-647. doi: 10.1111/ajo.12529. Epub 2016 Sep 9. Timing and patterns of recurrence in epithelial ovarian cancer patients with no gross residual disease after primary debulking surgery Paik ES11, Lee YY1, Shim M1, Choi HJ1, Kim TJ1, Choi CH1, Lee JW1, Kim BG1, Bae DS1.
    View PubMed
  • Gynecol Oncol. 2016 Nov;143(2):252-257. doi: 10.1016/j.ygyno.2016.08.321. Epub 2016 Aug 25. Impact of lymphadenectomy on survival after recurrence in patients with advanced ovarian cancer without suspected lymph node metastasis Paik ES11, Shim M1, Choi HJ1, Lee YY2, Kim TJ1, Lee JW1, Kim BG1, Bae DS1, Choi CH3.
    View PubMed
  • J Gynecol Oncol. 2016 Nov;27(6):e64. doi: 10.3802/jgo.2016.27.e64. The 5th Shanghai Gynecologic Oncology Group (SGOG)-Korean Gynecologic Oncology Group (KGOG) joint meeting and 2016 Asia-Pacific Ovarian cancer Laparotomy and Laparoscopic Operation (APOLLO) symposium in Shanghai Chang HK11, Kim BG2, Shi TY3, Zang R4.
    View PubMed
  • INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9(10):19654-19663 Pulmonary benign metastasizing leiomyoma: clinical and therapeutic analyses of 11 patients treated at a single institution Kim HS1, Yoon G, Lee JS, Han J, Song SY, Kim BG, Bae DS, Lee JW
    View PubMed
  • Int J Gynecol Cancer. 2016 Sep;26(7):1252-7. doi: 10.1097/IGC.0000000000000762. Long-term Outcomes of MRI Stage IIB Cervical Cancer Yoon A11, Park JJ, Park BK, Lee YY, Paik ES, Choi CH, Kim TJ, Kim CK, Lee JW, Bae DS, Kim BG.
    View PubMed
  • J Gynecol Oncol. 2016 Sep;27(5):e46. doi: 10.3802/jgo.2016.27.e46. Epub 2016 May 9. Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer Paik ES11, Kim TJ2, Lee YY1, Choi CH1, Lee JW1, Kim BG1, Bae DS1.
    View PubMed
  • J Clin Oncol. 2016 Aug 20;34(24):2881-7. doi: 10.1200/JCO.2016.66.9010. Epub 2016 Jul 11. Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial Sugiyama T11, Okamoto A2, Enomoto T1, Hamano T1, Aotani E1, Terao Y1, Suzuki N1, Mikami M1, Yaegashi N1, Kato K1, Yoshikawa H1, Yokoyama Y1, Tanabe H1, Nishino K1, Nomura H1, Kim JW1, Kim BG1, Pignata S1, Alexandre J1, Green J1, Isonishi S1, Terauchi F1, Fujiwara K1, Aoki D1.
    View PubMed
  • J Gynecol Oncol. 2016 Jul;27(4):e38. doi: 10.3802/jgo.2016.27.e38. Epub 2016 Apr 18. Long-term outcomes of magnetic resonance imaging-invisible endometrial cancer Choi HJ11, Lee S2, Park BK3, Kim TJ1, Kim CK2, Park JJ2, Choi CH1, Lee YY1, Lee JW1, Bae DS1, Kim BG1.
    View PubMed
  • Gynecol Oncol. 2016 Jun;141(3):440-446. doi: 10.1016/j.ygyno.2016.03.031. Epub 2016 Apr 8. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis Kim TH11, Kim HS2, Kim TJ3, Chang SJ4, Kim DY5, Ryu SY1, Kim BG3, Kim YT6, Bae DS3, Ryu HS4, Nam JH6.
    View PubMed
  • J Transl Med. 2016 May 6;14(1):124. doi: 10.1186/s12967-016-0874-0. Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients Choi CH11,2, Chung JY1, Kim JH3, Kim BG4, Hewitt SM5.
    View PubMed
  • J Gynecol Oncol. 2016 May;27(3):e24. doi: 10.3802/jgo.2016.27.e24. Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer Paik ES11, Lee YY1, Kim TJ1, Choi CH1, Lee JW2, Kim BG1, Bae DS1.
    View PubMed
  • J Gynecol Oncol. 2016 May;27(3):e27. doi: 10.3802/jgo.2016.27.e27. Time-lapse imaging of sentinel lymph node using indocyanine green with near-infrared fluorescence imaging in early endometrial cancer Choi HJ11, Kim TJ2, Lee YY1, Lee JW1, Kim BG1, Bae DS1.
    View PubMed
  • Mol Cancer Ther. 2016 Apr;15(4):618-27. doi: 10.1158/1535-7163.MCT-15-0733-T. Epub 2016 Feb 9. Linalool-Incorporated Nanoparticles as a Novel Anticancer Agent for Epithelial Ovarian Carcinoma Han HD11, Cho YJ2, Cho SK3, Byeon Y1, Jeon HN1, Kim HS4, Kim BG5, Bae DS5, Lopez-Berestein G6, Sood AK7, Shin BC8, Park YM9, Lee JW10.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2016 Apr;199:208-12. doi: 10.1016/j.ejogrb.2015.07.018. Epub 2015 Aug 20. Women with double primary cancers of the colorectum and endometrium: do they have Lynch syndrome Song T11, Kim MK2, Lee YY3, Choi CH3, Kim TJ3, Lee JW3, Bae DS3, Kim BG4.
    View PubMed
  • JSLS. 2016 Apr-Jun;20(2). pii: e2016.00001. doi: 10.4293/JSLS.2016.00001 Retroperitoneal Approach in Single-Port Laparoscopic Hysterectomy Kim TH11, Kim CJ1, Kim TJ2, Lee YY2, Choi CH2, Lee JW2, Bae DS2, Kim BG2.
    View PubMed
  • J Gynecol Oncol. 2016 Mar;27(2):e20. doi: 10.3802/jgo.2016.27.e20. Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer Park JY11, Heo EJ1, Lee JW2, Lee YY1, Kim TJ1, Kim BG1, Bae DS1.
    View PubMed
  • Radiology. 2016 Mar;278(3):925-35. doi: 10.1148/radiol.2015150608. Epub 2015 Aug 27. Uterine Fibroids: Correlation of T2 Signal Intensity with Semiquantitative Perfusion MR Parameters in Patients Screened for MR-guided High-Intensity Focused Ultrasound Ablation Kim YS11, Lee JW1, Choi CH1, Kim BG1, Bae DS1, Rhim H1, Lim HK1.
    View PubMed
  • BMC Cancer. 2016 Jan 6;16:5. doi: 10.1186/s12885-015-2040-0. Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea Park B11,2, Park S3,4, Shin HR5, Shin A6,7, Yeo Y8, Choi JY9, Jung KW10, Kim BG11, Kim YM12, Noh DY13, Ahn SH14, Kim JW15, Kang S16, Kim JH17, Kim TJ18, Kang D19,20,21, Yoo KY22, Park SK23,24,25.
    View PubMed
  • Arch Gynecol Obstet. 2016 Jan;293(1):157-62. doi: 10.1007/s00404-015-3801-3. Epub 2015 Jul 9. Clinical outcomes of primary surgical treatment for acquired vulvar lymphangioma circumscriptum Yoon G11, Kim HS2, Lee YY3, Kim TJ3, Choi CH3, Kim BG3, Bae DS3, Hwang JH4, Lee JW5.
    View PubMed
  • Oncotarget. 2015 Nov 3;6(34):36219-30. doi: 10.18632/oncotarget.5283. HER2 as a novel therapeutic target for cervical cancer Oh DY11,2,3, Kim S1, Choi YL1,2,3, Cho YJ4, Oh E2,3, Choi JJ4, Jung K3, Song JY2, Ahn SE2, Kim BG4, Bae DS4, Park WY3,5, Lee JW2,3,4, Song S1,2.
    View PubMed
  • J Gynecol Oncol. 2015 Oct;26(4):277-83. doi: 10.3802/jgo.2015.26.4.277. Epub 2015 Sep 23. Controversies in the management of endometrial cancer: a survey of the Korean Gynecologic Oncology Group Lee JY11, Kim K2, Lee TS3, Kang S4, Seong SJ5, Kim JW6, Kim BG7.
    View PubMed
  • J Gynecol Oncol. 2015 Oct;26(4):270-6. doi: 10.3802/jgo.2015.26.4.270. Epub 2015 Jul 17. Pulmonary metastasectomy in uterine malignancy: outcomes and prognostic factors Paik ES11, Yoon A1, Lee YY1, Kim TJ1, Lee JW1, Bae DS1, Kim BG2.
    View PubMed
  • Oncotarget. 2015 Oct 27;6(33):35040-50. doi: 10.18632/oncotarget.5319. Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma Lee YY11, Jeon HK1, Hong JE1, Cho YJ1, Ryu JY1, Choi JJ1, Lee SH2, Yoon G3, Kim WY4, Do IG5, Kim MK6, Kim TJ1, Choi CH1, Lee JW1, Bae DS1, Kim BG1.
    View PubMed
  • Oncotarget. 2015 Sep 29;6(29):26746-56. doi: 10.18632/oncotarget.4818. Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer Kim HS11, Yoon G2, Ryu JY3, Cho YJ3, Choi JJ3, Lee YY3, Kim TJ3, Choi CH3, Song SY4, Kim BG3, Bae DS3, Lee JW3,5.
    View PubMed
  • J Gynecol Oncol. 2015 Jul;26(3):222-6. doi: 10.3802/jgo.2015.26.3.222. Robotic high para-aortic nymph node dissection with high port placement using same port for pelvic surgery in gynecologic cancer patients Kim TJ11, Yoon G2, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG3.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2015 Jul;190:26-30. doi: 10.1016/j.ejogrb.2015.04.005. Epub 2015 Apr 16. The effect of coexisting squamous cell lesions on prognosis in patients with cervical adenocarcinoma in situ Song T11, Lee YY2, Choi CH2, Kim TJ2, Lee JW2, Bae DS2, Kim BG3.
    View PubMed
  • Int J Gynecol Cancer. 2015 Jul;25(6):1051-7. doi: 10.1097/IGC.0000000000000407. Perioperative Outcomes of Radical Trachelectomy in Early-Stage Cervical Cancer Vaginal Versus Laparoscopic Approaches Yoon A11, Choi CH, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2015 Jul;190:48-51. doi: 10.1016/j.ejogrb.2015.04.014. Epub 2015 May 1. A prospective comparative study of cosmetic satisfaction for three different surgical approaches Song T11, Park JY2, Kim TJ3, Lee YY2, Choi CH2, Lee JW2, Bae DS2, Kim BG2.
    View PubMed
  • Int J Cancer. 2015 Jul 1;137(1):221-9. doi: 10.1002/ijc.29362. Epub 2014 Dec 8. Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer Lee JW11, Ryu JY, Yoon G, Jeon HK, Cho YJ, Choi JJ, Song SY, Do IG, Lee YY, Kim TJ, Choi CH, Kim BG, Bae DS.
    View PubMed
  • Gynecol Oncol. 2015 Jun;137(3):412-7. doi: 10.1016/j.ygyno.2015.03.058. Epub 2015 Apr 11. The clinical value of surgeons' efforts of preventing intraoperative tumor rupture in stage I clear cell carcinoma of the ovary: A Korean multicenter study Suh DH11, Park JY2, Lee JY3, Kim BG4, Lim MC5, Kim JW3, Bae DS4, Park SY5, Nam JH2, Kim K1, No JH1, Kim YB6.
    View PubMed
  • Hum Pathol. 2015 Jun;46(6):884-93. doi: 10.1016/j.humpath.2015.02.016. Epub 2015 Mar 11. Pancreatic adenocarcinoma up-regulated factor expression is associated with disease-specific survival in cervical cancer patients Choi CH11, Chung JY2, Park HS3, Jun M2, Lee YY4, Kim BG5, Hewitt SM6.
    View PubMed
  • Int J Clin Exp Pathol. 2015 May 1;8(5):5318-26. eCollection 2015. Mesothelial cell inclusions in pelvic and para-aortic lymph nodes: a clinicopathologic analysis Kim HS11, Yoon G2, Lee YY3, Kim TJ3, Choi CH3, Lee JW3, Kim BG3, Bae DS3, Song SY4.
    View PubMed
  • Int J Gynecol Cancer. 2015 May;25(4):688-93. doi: 10.1097/IGC.0000000000000404. Correlation Between Location of Transposed Ovary and Function in Cervical Cancer Patients Who Underwent Radical Hysterectomy Yoon A11, Lee YY, Park W, Huh SJ, Choi CH, Kim TJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • Int J Clin Exp Pathol. 2015 May 1;8(5):5688-94. eCollection 2015. Analysis of clinical outcomes of patients with adenoid cystic carcinoma of Bartholin glands Yoon G11, Kim HS2, Lee YY3, Kim TJ3, Choi CH3, Song SY4, Kim BG3, Bae DS3, Lee JW3.
    View PubMed
  • Int J Clin Exp Pathol. 2015 May 1;8(5):5749-52. eCollection 2015. Primary ovarian carcinoid tumor showing unusual histology and nuclear accumulation of beta-catenin Kim HS11, Yoon G2, Jang HI3, Song SY4, Kim BG3.
    View PubMed
  • Taiwan J Obstet Gynecol. 2015 Apr;54(2):150-4. doi: 10.1016/j.tjog.2014.05.005. Is laparoendoscopic single-site surgery (LESS) retroperitoneal hysterectomy feasible: Surgical outcomes of the initial 27 cases Kim TH11, Kim TJ2, Yoo HN1, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG1.
    View PubMed
  • PLoS One. 2015 Feb 6;10(2):e0116977. doi: 10.1371/journal.pone.0116977. eCollection 2015. Somatic Copy Number Alterations Associated with Japanese or Endometriosis in Ovarian Clear Cell Adenocarcinoma Okamoto A11, Sehouli J2, Yanaihara N1, Hirata Y1, Braicu I2, Kim BG3, Takakura S1, Saito M1, Yanagida S1, Takenaka M1, Yamaguchi N1, Morikawa A1, Tanabe H1, Yamada K1, Yoshihara K4, Enomoto T4, Itamochi H5, Kigawa J5, Matsumura N6, Konishi I6, Aida S7, Aoki Y8, Ishii N8, Ochiai K1, Akiyama T7, Urashima M9.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2015 Jan;184:38-42. doi: 10.1016/j.ejogrb.2014.10.001. Epub 2014 Oct 14. Borderline ovarian tumor in women aged >= 65 years: impact on recurrence and survival Song T11, Lee YY2, Choi CH2, Kim TJ2, Lee JW2, Bae DS2, Kim BG3.
    View PubMed
  • J Gynecol Oncol. 2015 Jan;26(1):68-74. doi: 10.3802/jgo.2015.26.1.68. Asian Society of Gynecologic Oncology International Workshop 2014 Park JY11, Ngan HY2, Park W3, Cao Z4, Wu X5, Ju W6, Chung HH7, Chang SJ8, Park SY9, Ryu SY10, Kim JH11, Cho CH12, Lee KH13, Lee JW14, Kumarasamy S15, Kim JW7, Wilailak S16, Kim BG14, Kim DY1, Konishi I17, Lee JK18, Wang KL19, Nam JH20.
    View PubMed
  • J Gynecol Oncol. 2015 Jan;26(1):62-7. doi: 10.3802/jgo.2015.26.1.62. Single-site robotic surgery in gynecologic cancer: a pilot study Yoo HN11, Kim TJ2, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG1.
    View PubMed
  • Int J Clin Exp Pathol. 2015 Jan 1;8(1):1025-30. eCollection 2015. Decidualization of intranodal endometriosis in a postmenopausal woman Kim HS11, Yoon G2, Kim BG2, Song SY1.
    View PubMed
  • Radiology. 2014 Nov;273(2):462-71. doi: 10.1148/radiol.14132719. Epub 2014 Jul 1. Uterine Fibroids: Semiquantitative Perfusion MR Imaging Parameters Associated with the Intraprocedural and Immediate Postprocedural Treatment Efficiencies of MR Imaging-guided High-Intensity Focused Ultrasound Ablation Kim YS11, Kim BG, Rhim H, Bae DS, Lee JW, Kim TJ, Choi CH, Lee YY, Lim HK.
    View PubMed
  • Gynecol Oncol. 2014 Oct;135(1):108-17. doi: 10.1016/j.ygyno.2014.06.031. Epub 2014 Jul 9. Dual targeting of angiotensin receptors (AGTR1 and AGTR2) in epithelial ovarian carcinoma Park YA11, Choi CH1, Do IG2, Song SY2, Lee JK3, Cho YJ1, Choi JJ1, Jeon HK1, Ryu JY1, Lee YY1, Kim TJ1, Bae DS1, Lee JW4, Kim BG5.
    View PubMed
  • J Clin Oncol. 2014 Oct 20;32(30):3374-82. doi: 10.1200/JCO.2014.55.7348. Epub 2014 Sep 15. Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer du Bois A11, Floquet A1, Kim JW1, Rau J1, del Campo JM1, Friedlander M1, Pignata S1, Fujiwara K1, Vergote I1, Colombo N1, Mirza MR1, Monk BJ1, Kimmig R1, Ray-Coquard I1, Zang R1, Diaz-Padilla I1, Baumann KH1, Mouret-Reynier MA1, Kim JH1, Kurzeder C1, Lesoin A1, Vasey P1, Marth C1, Canzler U1, Scambia G1, Shimada M1, Calvert P1, Pujade-Lauraine E1, Kim BG1, Herzog TJ1, Mitrica I1, Schade-Brittinger C1, Wang Q1, Crescenzo R1, Harter P1.
    View PubMed
  • Int J Gynecol Cancer. 2014 Oct;24(8):1466-73. doi: 10.1097/IGC.0000000000000232. Robotic Versus Laparoscopic Radical Hysterectomy in Cervical Cancer Patients A Matched-Case Comparative Study Kim TH11, Choi CH, Choi JK, Yoon A, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Int J Gynecol Cancer. 2014 Sep;24(7):1299-305. doi: 10.1097/IGC.0000000000000197. Prognostic Factors Influencing Decisions About Surgical Treatment of Villoglandular Adenocarcinoma of the Uterine Cervix Kim HJ11, Sung JH, Lee E, Ahn S, Song SY, Choi CH, Kim TJ, Kim BG, Bae DS, Lee JW.
    View PubMed
  • Taiwan J Obstet Gynecol. 2014 Sep;53(3):343-7. doi: 10.1016/j.tjog.2013.10.041. Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings Kim HJ11, Choi CH2, Lee YY2, Kim TJ2, Lee JW2, Bae DS2, Kim BG3.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):140-6. doi: 10.1016/j.ijrobp.2014.05.024. Epub 2014 Jul 8. A Phase 2 Trial of Radiation Therapy With Concurrent Paclitaxel Chemotherapy After Surgery in Patients With High-Risk Endometrial Cancer: A Korean Gynecologic Oncologic Group Study Cho H11, Nam BH2, Kim SM3, Cho CH4, Kim BG5, Ryu HS6, Kang SB7, Kim JH8.
    View PubMed
  • Int J Gynecol Cancer. 2014 Sep;24(7):1206-14. doi: 10.1097/IGC.0000000000000216. Risk Factors for Progression to Invasive Carcinoma in Patients With Borderline Ovarian Tumors Song T11, Lee YY, Choi CH, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Am J Obstet Gynecol. 2014 Aug;211(2):168.e1-7. doi: 10.1016/j.ajog.2014.02.032. Epub 2014 Mar 4. Postoperative outcomes of MR-invisible stage IB1 cervical cancer Park JY11, Lee JW1, Park BK2, Lee YY1, Choi CH1, Kim TJ1, Bae DS1, Kim BG1, Park JJ3, Park SY3, Kim CK3.
    View PubMed
  • J Cancer Res Clin Oncol. 2014 Jul;140(7):1179-88. doi: 10.1007/s00432-014-1658-7. Epub 2014 Mar 27. Meta-analysis of the effects of beta blocker on survival time in cancer patients Choi CH11, Song T, Kim TH, Choi JK, Park JY, Yoon A, Lee YY, Kim TJ, Bae DS, Lee JW, Kim BG.
    View PubMed
  • J Minim Invasive Gynecol. 2014 Jul-Aug;21(4):580-5. doi: 10.1016/j.jmig.2013.12.096. Epub 2013 Dec 31. Surgical Outcomes of a New Approach to Laparoscopic Myomectomy: Single-Port and Modified Suture Technique Choi CH11, Kim TH1, Kim SH1, Choi JK1, Park JY1, Yoon A1, Lee YY1, Kim TJ1, Lee JW1, Kim BG1, Bae DS2.
    View PubMed
  • Support Care Cancer. 2014 May;22(5):1181-7. doi: 10.1007/s00520-013-2070-6. Epub 2013 Dec 12. Safety and efficacy of aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in patients with ovarian cancer treated with paclitaxel/carboplatin Choi CH11, Kim MK, Park JY, Yoon A, Kim HJ, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • J Laparoendosc Adv Surg Tech A. 2014 Apr;24(4):254-9. doi: 10.1089/lap.2013.0507. Epub 2014 Feb 25. Comparison of Laparoendoscopic Single-Site Hysterectomies: Laparoscopic Hysterectomy with Some Vaginal Component Versus Laparoscopically Assisted Vaginal Hysterectomy Kim TJ11, Song T, Choi CH, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2014 Apr;175:58-61. doi: 10.1016/j.ejogrb.2014.01.004. Epub 2014 Jan 17. Laparoendoscopic single-site (LESS) myomectomy: characteristics of the appropriate myoma Yoon A11, Kim TJ1, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG2.
    View PubMed
  • Clin Cancer Res. 2014 Feb 1;20(3):565-75. doi: 10.1158/1078-0432.CCR-13-1271. Epub 2013 Nov 6. Tumor Suppressive Effects of Bromodomain-Containing Protein 7 (BRD7) in Epithelial Ovarian Carcinoma Park YA11, Lee JW, Kim HS, Lee YY, Kim TJ, Choi CH, Choi JJ, Jeon HK, Cho YJ, Ryu JY, Kim BG, Bae DS.
    View PubMed
  • PLoS One. 2014 Feb 11;9(2):e88587. doi: 10.1371/journal.pone.0088587. eCollection 2014. Targeted Inhibition of FAK, PYK2 and BCL-XL Synergistically Enhances Apoptosis in Ovarian Clear Cell Carcinoma Cell Lines Yoon H11, Choi YL2, Song JY1, Do I3, Kang SY4, Ko YH5, Song S4, Kim BG6.
    View PubMed
  • Gynecol Oncol. 2014 Jan;132(1):70-5. doi: 10.1016/j.ygyno.2013.10.029. Epub 2013 Oct 31. Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: A multicenter review of 114 cases Yoon A11, Park JY2, Park JY1, Lee YY1, Kim TJ1, Choi CH1, Bae DS1, Kim BG1, Lee JW3, Nam JH4.
    View PubMed
  • Int J Gynecol Cancer. 2014 Jan;24(1):107-12. doi: 10.1097/IGC.0000000000000015. Bone Metastasis in Primary Endometrial Carcinoma Features, Outcomes, and Predictors Yoon A11, Choi CH, Kim TH, Choi JK, Park JY, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Gynecol Oncol. 2013 Dec;131(3):650-4. doi: 10.1016/j.ygyno.2013.10.003. Epub 2013 Oct 18. Genetic profiling to predict recurrence of early cervical cancer Lee YY11, Kim TJ, Kim JY, Choi CH, Do IG, Song SY, Sohn I, Jung SH, Bae DS, Lee JW, Kim BG.
    View PubMed
  • Gynecol Oncol. 2013 Nov;131(2):336-40. doi: 10.1016/j.ygyno.2013.07.110. Epub 2013 Aug 13. Use of complex surgical procedures, patterns of tumor spread, and CA-125 predicts a risk of incomplete cytoreduction: A Korean Gynecologic Oncology Group study (KGOG-3022) Jung DC11, Kang S, Kim SC, Kim JW, Nam JH, Ryu SY, Seong SJ, Kim BG.
    View PubMed
  • Gynecol Obstet Invest. 2013;76(4):241-7. doi: 10.1159/000356072. Epub 2013 Nov 1. Endocervical-Like versus intestinal-Type Mucinous Borderline Ovarian Tumors: A Large Retrospective Series Focusing on the Clinicopatholigic Characteristics Song T11, Choi CH, Lee YY, Kim TJ, Lee JW, Sung CO, Song SY, Bae DS, Kim BG.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):659-64. doi: 10.1016/j.ijrobp.2013.07.020. Individualized Prediction of Overall Survival After Postoperative Radiation Therapy in Patients With Early-Stage Cervical Cancer: A Korean Radiation Oncology Group Study (KROG 13-03) Lee HJ11, Han S, Kim YS, Nam JH, Kim HJ, Kim JW, Park W, Kim BG, Kim JH, Cha SD, Kim J, Lee KH, Yoon MS, Kim SM, Kim JY, Yoon WS, Lee NW, Choi JH, Park SY, Kim JY.
    View PubMed
  • J Gynecol Oncol. 2013 Oct;24(4):291-2. doi: 10.3802/jgo.2013.24.4.291. Epub 2013 Oct 2. Squamous cell carcinoma antigen in cervical cancer and beyond 1,Kim BG1.
    View PubMed
  • Int J Gynecol Cancer. 2013 Sep;23(7):1311-7. doi: 10.1097/IGC.0b013e31829da127. Contributing Factors for Bone Metastasis in Uterine Cervical Cancer Yoon A11, Choi CH, Kim HJ, Park JY, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Gynecol Oncol. 2013 Jul;130(1):25-30. doi: 10.1016/j.ygyno.2013.04.011. Epub 2013 Apr 13. A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinoma Herzog TJ11, Scambia G, Kim BG, Lhomm? C, Markowska J, Ray-Coquard I, Sehouli J, Colombo N, Shan M, Petrenciuc O, Oza A.
    View PubMed
  • Hum Pathol. 2013 Jun;44(6):1017-23. doi: 10.1016/j.humpath.2012.08.024. Epub 2013 Jan 3. Overexpression of annexin A4 is associated with chemoresistance in papillary serous adenocarcinoma of the ovary Choi CH11, Sung CO, Kim HJ, Lee YY, Song SY, Song T, Kim J, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Cancer Genet. 2013 May;206(5):145-53. doi: 10.1016/j.cancergen.2013.04.002. Epub 2013 May 29. Integrative analysis of copy number alteration and gene expression profiling in ovarian clear cell adenocarcinoma Sung CO11, Choi CH, Ko YH, Ju H, Choi YL, Kim N, Kang SY, Ha SY, Choi K, Bae DS, Lee JW, Kim TJ, Song SY, Kim BG.
    View PubMed
  • J Gynecol Oncol. 2013 Apr;24(2):120-7. doi: 10.3802/jgo.2013.24.2.120. Epub 2013 Apr 5. A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system Kim HJ11, Kim TJ, Lee YY, Choi CH, Lee JW, Bae DS, Kim BG.
    View PubMed
  • J Gynecol Oncol. 2013 Apr;24(2):186-203. doi: 10.3802/jgo.2013.24.2.186. Epub 2013 Apr 5. Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition Lee JK11, Hong JH, Kang S, Kim DY, Kim BG, Kim SH, Kim YM, Kim JW, Kim JH, Kim TJ, Kim HJ, Kim HS, Ryu HS, Song JY, Ahn HS, Yoo CW, Yoon HK, Lee KH, Lee A, Lee Y, Lee IH, Lee JW, Lee TS, Lim MC, Chang SJ, Chung HH, Ju W, Joo HJ, Hur SY, Hong SR, Nam JH.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2013 Apr;167(2):215-8. doi: 10.1016/j.ejogrb.2012.11.027. Epub 2013 Jan 14. Laparoendoscopic single site (LESS) surgery in benign gynecology: perioperative and late complications of 515 cases 1,http://www.ncbi.nlm.nih.gov/pubmed/?term=Laparoendoscopic+single+site+(LESS)+surgery+in+benign+gynecology%3A+perioperative+and+late+complications+of+515+cases
    View PubMed
  • J Minim Invasive Gynecol. 2013 Mar-Apr;20(2):160-5. doi: 10.1016/j.jmig.2012.09.013. Epub 2013 Jan 11. Laparoendoscopic Single-Site Surgery With Hysterectomy in Patients With Prior Cesarean Section: Comparison of Surgical Outcomes With Bladder Dissection Techniques Jo EJ11, Kim TJ, Lee YY, Choi CH, Lee JW, Bae DS, Kim BG.
    View PubMed
  • J Gynecol Oncol. 2013 Jan;24(1):44-51. doi: 10.3802/jgo.2013.24.1.44. Epub 2013 Jan 8. Histologic distribution of borderline ovarian tumors worldwide: a systematic review Song T11, Lee YY, Choi CH, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Int J Clin Oncol. 2012 Dec;17(6):590-7. doi: 10.1007/s10147-011-0329-9. Epub 2011 Oct 13. Ploidy and S-phase fraction are correlated with lymphovascular space invasion that is predictive of outcomes in endometrial cancer Song T11, Lee JW, Choi CH, Kim TJ, Bae DS, Sung CO, Song SY, Kim BG.
    View PubMed
  • Gynecol Obstet Invest. 2012;74(4):313-9. doi: 10.1159/000338996. Epub 2012 Oct 11. Uterine Endometrial Carcinoma: 10 Years' Experience with Long-Term Follow-Up at a Single Korean Institution Lee EJ11, Kim TJ, Choi CH, Lee JW, Lee JH, Bae DS, Park HM, Kim BG.
    View PubMed
  • Gynecol Oncol. 2012 Oct;127(1):107-13. doi: 10.1016/j.ygyno.2012.05.039. Epub 2012 Jun 15. Clinical significance of changes in peripheral lymphocyte count after surgery in early cervical cancer Lee YY11, Choi CH, Sung CO, Do IG, Hub SJ, Kim HJ, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • J Gynecol Oncol. 2012 Oct;23(4):226-34. doi: 10.3802/jgo.2012.23.4.226. Epub 2012 Sep 19. Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer Park JY11, Kim DY, Kim JH, Kim YM, Kim YT, Kim YS, Kim HJ, Lee JW, Kim BG, Bae DS, Huh SJ, Nam JH.
    View PubMed
  • Aust N Z J Obstet Gynaecol. 2012 Oct;52(5):465-9. doi: 10.1111/j.1479-828X.2012.01466.x. Cosmesis and body image after single-port access surgery for gynaecologic disease Song T11, Kim TJ, Cho J, Kim IR, Kang PN, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Eur J Cancer. 2012 Aug;48(12):1914-21. doi: 10.1016/j.ejca.2012.02.005. Epub 2012 Mar 2. High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion Kim HJ11, Jeon HK, Cho YJ, Park YA, Choi JJ, Do IG, Song SY, Lee YY, Choi CH, Kim TJ, Bae DS, Lee JW, Kim BG.
    View PubMed
  • Asian Pac J Cancer Prev. 2012;13(8):3731-40. Korean Epithelial Ovarian Cancer Study (Ko-EVE): Protocols and Interim Report Ma SH11, Kim BG, Choi JY, Kim TJ, Kim YM, Kim JW, Kang S, Kang D, Yoo KY, Park SK.
    View PubMed
  • Br J Cancer. 2012 Jun 26;107(1):91-9. doi: 10.1038/bjc.2012.217. Epub 2012 May 29. Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival Choi CH11, Choi JJ, Park YA, Lee YY, Song SY, Sung CO, Song T, Kim MK, Kim TJ, Lee JW, Kim HJ, Bae DS, Kim BG.
    View PubMed
  • Cancer Res Treat. 2012 Jun;44(2):142-5. doi: 10.4143/crt.2012.44.2.142. Epub 2012 Jun 30. Metastatic Skin Lesions on Lower Extremities in a Patient with Recurrent Serous Papillary Ovarian Carcinoma: A Case Report and Literature Review Kim MK11, Kim SH, Lee YY, Choi CH, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG.
    View PubMed
  • Ann Surg Oncol. 2012 Jun;19(6):1973-9. doi: 10.1245/s10434-011-2148-7. Epub 2011 Dec 20. Safe Criteria for Less Radical Trachelectomy in Patients with Early-Stage Cervical Cancer: A Multicenter Clinicopathologic Study Kim HS11, Choi CH, Lim MC, Chang SJ, Kim YB, Kim MA, Kim TJ, Park SY, Kim BG, Song YS, Bae DS, Kim JW.
    View PubMed
  • Gynecol Oncol. 2012 May;125(2):427-32. doi: 10.1016/j.ygyno.2012.01.030. Epub 2012 Jan 28. Expression of 67-kDa laminin receptor was associated with tumor progression and poor prognosis in epithelial ovarian cancer Song T11, Choi CH, Cho YJ, Sung CO, Song SY, Kim TJ, Bae DS, Lee JW, Kim BG.
    View PubMed
  • PLoS One. 2012;7(5):e35399. doi: 10.1371/journal.pone.0035399. Epub 2012 May 18. Thymosin beta(10) Expression Driven by the Human TERT Promoter Induces Ovarian Cancer-Specific Apoptosis through ROS Production Kim YC11, Kim BG, Lee JH.
    View PubMed
  • Int J Gynecol Cancer. 2012 May;22(4):611-6. doi: 10.1097/IGC.0b013e318249472d. Patterns of Recurrence in Endometrial Cancer Patients at Risk of Lymph Node Metastasis or Recurrence According to Extent of Lymphadenectomy Kim HJ11, Kim TJ, Song T, Kim MK, Lee YY, Choi CH, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Anticancer Res. 2012 Apr;32(4):1555-61. Pretreatment Neutrophil:Lymphocyte Ratio as a Prognostic Factor in Cervical Carcinoma Lee YY11, Choi CH, Kim HJ, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG.
    View PubMed
  • J Gynecol Oncol. 2012 Jan;23(1):72-3. doi: 10.3802/jgo.2012.23.1.72. Epub 2012 Jan 9. Hereditary portion as an initial genetic approach in gynecologic cancer: synchronous tumor of ovary and endometrium In reply Yoo HJ11, Park SY, Lim MC.
    View PubMed
  • Taiwan J Obstet Gynecol. 2011 Dec;50(4):436-40. doi: 10.1016/j.tjog.2011.10.007. Single-port access laparoscopic surgery using a novel laparoscopic port (Octo-Port) Song T11, Kim TJ, Kang HJ, Choi CH, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1252-7. doi: 10.1016/j.ijrobp.2010.07.2006. Epub 2010 Nov 13. A MATCHED-CASE COMPARISON TO EXPLORE THE ROLE OF CONSOLIDATION CHEMOTHERAPY AFTER CONCURRENT CHEMORADIATION IN CERVICAL CANCER Choi CH11, Lee YY, Kim MK, Kim TJ, Lee JW, Nam HR, Huh SJ, Lee JH, Bae DS, Kim BG.
    View PubMed
  • J Gynecol Oncol. 2011 Dec;22(4):233-8. doi: 10.3802/jgo.2011.22.4.233. Epub 2011 Dec 5. Synchronous gynecologic malignancy and preliminary results of Lynch syndrome Kim MK11, Song SY, Do IG, Kim SH, Choi CH, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Gynecol Oncol. 2011 Sep;122(3):541-7. doi: 10.1016/j.ygyno.2011.05.009. Epub 2011 Jun 2. Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: A meta-analysis Lee YY11, Kim TJ, Kim MJ, Kim HJ, Song T, Kim MK, Choi CH, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Hum Reprod. 2011 Aug;26(8):2008-14. doi: 10.1093/humrep/der119. Epub 2011 Apr 21. Oncologic and reproductive outcomes of cystectomy compared with oophorectomy as a treatment for borderline ovarian tumours Song T11, Hun Choi C, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Gynecol Oncol. 2011 Aug;122(2):361-5. doi: 10.1016/j.ygyno.2011.04.025. Epub 2011 May 13. Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy Lee YY11, Choi CH, Do IG, Song SY, Lee W, Park HS, Song TJ, Kim MK, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Gynecol Oncol. 2011 Jul;122(1):79-82. doi: 10.1016/j.ygyno.2011.03.017. Epub 2011 Apr 13. Prognostic significance of DNA ploidy in stage I endometrial cancer Song T11, Lee JW, Kim HJ, Kim MK, Choi CH, Kim TJ, Bae DS, Kim BG.
    View PubMed
  • Gynecol Oncol. 2011 Jul;122(1):127-31. doi: 10.1016/j.ygyno.2011.03.021. Epub 2011 Apr 13. Accuracy of frozen section diagnosis of borderline ovarian tumors Song T11, Choi CH, Kim HJ, Kim MK, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Cancer Res Treat. 2011 Jun;43(2):131-3. doi: 10.4143/crt.2011.43.2.131. Epub 2011 Jun 30. Benign Metastasizing Leiomyoma with Multiple Lymph Node Metastasis: A Case Report Yoon G11, Kim TJ, Sung CO, Choi CH, Lee JW, Lee JH, Bae DS, Kim BG.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2011 Jun;156(2):204-8. doi: 10.1016/j.ejogrb.2011.01.009. Epub 2011 Feb 8. Oncologic and reproductive outcomes in patients with advanced-stage borderline ovarian tumors Song T11, Choi CH, Kim HJ, Lee W, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Cancer. 2011 May 15;117(10):2104-11. doi: 10.1002/cncr.25710. Epub 2010 Nov 29. Phase II Study of Belotecan, a Camptothecin Analogue, in Combination With Carboplatin for the Treatment of Recurrent Ovarian Cancer Choi CH11, Lee YY, Song TJ, Park HS, Kim MK, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG.
    View PubMed
  • Int J Gynecol Cancer. 2011 May;21(4):640-6. doi: 10.1097/IGC.0b013e3182129842. Fertility-Sparing Surgery for Borderline Ovarian Tumors Oncologic Safety and Reproductive Outcomes Song T11, Choi CH, Park HS, Kim MK, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Eur J Cancer. 2011 Apr;47(6):918-25. doi: 10.1016/j.ejca.2010.11.007. Epub 2010 Dec 4. High claudin-7 expression is associated with a poor response to platinum-based chemotherapy in epithelial ovarian carcinoma Kim CJ11, Lee JW, Choi JJ, Choi HY, Park YA, Jeon HK, Sung CO, Song SY, Lee YY, Choi CH, Kim TJ, Lee JH, Kim BG, Bae DS.
    View PubMed
  • J Gynecol Oncol. 2011 Mar 31;22(1):44-8. doi: 10.3802/jgo.2011.22.1.44. Clinical significance of HIF-2 alpha immunostaining area in radioresistant cervical cancer Kim MK11, Kim TJ, Sung CO, Choi CH, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Exp Mol Med. 2011 Feb 28;43(2):91-100. AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration Park K11, Chung YJ, So H, Kim K, Park J, Oh M, Jo M, Choi K, Lee EJ, Choi YL, Song SY, Bae DS, Kim BG, Lee JH.
    View PubMed
  • Gynecol Oncol. 2011 Jan;120(1):18-22. doi: 10.1016/j.ygyno.2010.09.024. Epub 2010 Oct 28. Interaction between preoperative CA-125 level and survival benefit of neoadjuvant chemotherapy in advanced epithelial ovarian cancer Kang S11, Kim TJ, Seo SS, Kim BG, Bae DS, Park SY.
    View PubMed
  • Gynecol Oncol. 2011 Jan;120(1):56-62. doi: 10.1016/j.ygyno.2010.09.022. Epub 2010 Oct 28. The expression of the miRNA-200 family in endometrial endometrioid carcinoma Lee JW11, Park YA, Choi JJ, Lee YY, Kim CJ, Choi C, Kim TJ, Lee NW, Kim BG, Bae DS.
    View PubMed
  • J Gynecol Oncol. 2010 Dec 30;21(4):241-7. doi: 10.3802/jgo.2010.21.4.241. Epub 2010 Dec 31. Epidemiological characteristics of ovarian cancer in Korea Park B11, Park S, Kim TJ, Ma SH, Kim BG, Kim YM, Kim JW, Kang S, Kim J, Kim TJ, Yoo KY, Park SK.
    View PubMed
  • J Pediatr Surg. 2010 Oct;45(10):1955-60. doi: 10.1016/j.jpedsurg.2010.06.012. Pediatric borderline ovarian tumors: a retrospective analysis Song T11, Choi CH, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Gynecol Oncol. 2010 Oct;119(1):87-91. doi: 10.1016/j.ygyno.2010.05.030. Epub 2010 Jun 26. Sequence-dependent hematologic side effects of topotecan and cisplatin in persistent or recurrent cervical cancer Lee YY11, Lee JW, Park HS, Song TJ, Kim MK, Choi CH, Kim TJ, Lee JH, Bae DS, Kim BG.
    View PubMed
  • Surg Endosc. 2010 Sep;24(9):2248-52. doi: 10.1007/s00464-010-0944-y. Epub 2010 Feb 23. Single-port-access laparoscopic-assisted vaginal hysterectomy versus conventional laparoscopic-assisted vaginal hysterectomy: a comparison of perioperative outcomes Kim TJ11, Lee YY, Cha HH, Kim CJ, Choi CH, Lee JW, Bae DS, Lee JH, Kim BG.
    View PubMed
  • Int J Gynecol Cancer. 2010 Aug;20(6):1017-24. doi: 10.1111/IGC.0b013e3181e4a704. Prevalence and Predictors of Anxiety and Depression Among Cervical Cancer Survivors in Korea Kim SH11, Kang S, Kim YM, Kim BG, Seong SJ, Cha SD, Park CY, Yun YH.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2010 Aug;151(2):181-4. doi: 10.1016/j.ejogrb.2010.03.010. Epub 2010 Apr 13. Single port access laparoscopic adnexal surgery versus conventional laparoscopic adnexal surgery: a comparison of pen-operative outcomes Lee YY11, Kim TJ, Kim CJ, Park HS, Choi CH, Lee JW, Lee JH, Bae DS, Kim BG.
    View PubMed
  • Int J Gynecol Cancer. 2010 Jul;20(5):798-803. Peritoneal Tuberculosis A Retrospective Review of 20 Cases and Comparison With Primary Peritoneal Carcinoma Choi CH11, Kim CJ, Lee YY, Kim JS, Song T, Park HS, Kim MK, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG.
    View PubMed
  • J Korean Med Sci. 2010 Apr;25(4):552-6. doi: 10.3346/jkms.2010.25.4.552. Epub 2010 Mar 19. Necessity of Radical Hysterectomy for Endometrial Cancer Patients with Cervical Invasion Lee TS11, Kim JW, Kim DY, Kim YT, Lee KH, Kim BG, McMeekin DS.
    View PubMed
  • FEBS Lett. 2010 Apr 16;584(8):1469-75. doi: 10.1016/j.febslet.2010.02.072. Epub 2010 Mar 6. Interaction of testisin with maspin and its impact on invasion and cell death resistance of cervical cancer cells Yeom SY11, Jang HL, Lee SJ, Kim E, Son HJ, Kim BG, Park C.
    View PubMed
  • Gynecol Oncol. 2010 Mar;116(3):533-8. doi: 10.1016/j.ygyno.2009.11.018. Epub 2009 Dec 14. p53 alteration independently predicts poor outcomes in patients with endometrial cancer: A clinicopathologic study of 131 cases and literature review Lee EJ11, Kim TJ, Kim DS, Choi CH, Lee JW, Lee JH, Bae DS, Kim BG.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2010 Mar;149(1):97-101. doi: 10.1016/j.ejogrb.2009.11.011. Epub 2009 Dec 16. The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries Kim WY11, Kim TJ, Kim SE, Lee JW, Lee JH, Kim BG, Bae DS.
    View PubMed
  • J Surg Oncol. 2010 Jan 1;101(1):13-7. doi: 10.1002/jso.21398. Preoperative Serum CA-125 Levels and Risk of Suboptimal Cytoreduction in Ovarian Cancer: A Meta-Analysis Kang S11, Kim TJ, Nam BH, Seo SS, Kim BG, Bae DS, Park SY.
    View PubMed
  • J Cancer Res Clin Oncol. 2009 Nov;135(11):1513-20. doi: 10.1007/s00432-009-0598-0. Epub 2009 May 16. In vitro extreme drug resistance assay to taxanes or platinum compounds for the prediction of clinical outcomes in epithelial ovarian cancer: a prospective cohort study Kim HS11, Kim TJ, Chung HH, Kim JW, Kim BG, Park NH, Song YS, Bae DS, Kang SB.
    View PubMed
  • J Korean Med Sci. 2009 Oct;24(5):945-50. doi: 10.3346/jkms.2009.24.5.945. Epub 2009 Sep 24. Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer Kang H11, Kim TJ, Choi CH, Lee JW, Lee JH, Bae DS, Kim BG.
    View PubMed
  • Gynecol Oncol. 2009 Oct;115(1):65-8. doi: 10.1016/j.ygyno.2009.06.022. Epub 2009 Jul 15. The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: Preliminary results Lee YY11, Choi CH, Kim CJ, Kang H, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG.
    View PubMed
  • Gynecol Oncol. 2009 Aug;114(2):210-4. doi: 10.1016/j.ygyno.2009.04.016. Epub 2009 May 14. Topotecan combined with carboplatin in recurrent epithelial ovarian cancer: Results of a single-institutional phase II study Kang H11, Kim TJ, Lee YY, Choi CH, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Ann Oncol. 2009 Jun;20(6):1032-6. doi: 10.1093/annonc/mdn764. Epub 2009 Feb 4. Prognostic significance of histological grade in clear-cell carcinoma of the ovary: a retrospective study of Korean Gynecologic Oncology Group Ryu SY11, Park SI, Nam BH, Kim I, Yoo CW, Nam JH, Lee KH, Cho CH, Kim JH, Park SY, Kim BG, Kang SB.
    View PubMed
  • Conization Using Electrosurgical Conization and Cold Coagulation for International Federation of Gynecology and Obstetrics Stage IA(1) Squamous Cell Carcinomas of the Uterine Cervix
  • Int J Gynecol Cancer. 2009 Jan;19(1):84-7. doi: 10.1111/IGC.0b013e31819914c5. Clinicopathologic Characteristics of Malignant Germ Cell Tumors in the Ovaries of Korean Women A Korean Gynecologic Oncology Group Study Lee KH11, Lee IH, Kim BG, Nam JH, Kim WK, Kang SB, Ryu SY, Cho CH, Choi HS, Kim KT; Korean Gynecologic Oncology Group.
    View PubMed
  • Oncology. 2009;76(3):190-8. doi: 10.1159/000201571. Epub 2009 Feb 11. Cross-Cultural Application of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Cervical Cancer Module Shin DW11, Ahn E, Kim YM, Kang S, Kim BG, Seong SJ, Cha SD, Park CY, Yun YH.
    View PubMed
  • Int J Gynecol Cancer. 2008 Sep-Oct;18(5):916-20. doi: 10.1111/j.1525-1438.2007.01146.x. Epub 2008 Jan 31. Retrospective multicenter study of a clinicopathologic analysis of pseudomyxoma peritonei associated with ovarian tumors (KGOG 3005) Lee JK11, Song SH, Kim I, Lee KH, Kim BG, Kim JW, Kim YT, Park SY, Cha MS, Kang SB.
    View PubMed
  • Clin Cancer Res. 2008 May 1;14(9):2535-42. doi: 10.1158/1078-0432.CCR-07-1231. Altered MicroRNA expression in cervical carcinomas Lee JW11, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG, Bae DS.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):199-204. Epub 2007 Nov 26. Prognostic value of baseline lymphocyte count in cervical carcinoma treated with concurrent chemoradiation Choi CH11, Kang H, Kim WY, Kim TJ, Lee JW, Huh SJ, Lee JH, Kim BG, Bae DS.
    View PubMed
  • Oncol Rep. 2008 Apr;19(4):859-63. Increased expression of calpain 6 during the progression of uterine cervical neoplasia: Immunohistochemical analysis Lee SJ11, Kim BG, Choi YL, Lee JW.
    View PubMed
  • Cancer Sci. 2008 Jan;99(1):31-8. Epub 2007 Nov 6. Gene expression profiling for the prediction of lymph node metastasis in patients with cervical cancer Kim TJ11, Choi JJ, Kim WY, Choi CH, Lee JW, Bae DS, Son DS, Kim J, Park BK, Ahn G, Cho EY, Kim BG.
    View PubMed
  • Int J Gynecol Cancer. 2007 Nov-Dec;17(6):1252-7. Epub 2007 Apr 18. Prognostic factors associated with brain metastases from epithelial ovarian carcinoma Kim TJ11, Song S, Kim CK, Kim WY, Choi CH, Lee JH, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Cancer Lett. 2007 Sep 18;255(1):26-33. Epub 2007 Apr 30. Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer Choi CH11, Lee KM, Choi JJ, Kim TJ, Kim WY, Lee JW, Lee SJ, Lee JH, Bae DS, Kim BG.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):817-22. Epub 2007 Mar 26. Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: Preliminary results Choi CH11, Lee JW, Kim TJ, Kim WY, Nam HR, Kim BG, Huh SJ, Lee JH, Bae DS.
    View PubMed
  • Gynecol Oncol. 2007 Jun;105(3):762-8. Epub 2007 Mar 26. Papillary serous carcinoma in ovaries of normal size: A clinicopathologic study of 20 cases and comparison with extraovarian peritoneal papillary serous carcinoma Choi CH11, Kim TJ, Kim WY, Ahn GH, Lee JW, Kim BG, Lee JH, Bae DS.
    View PubMed
  • Int J Gynecol Cancer. 2007 Jan-Feb;17(1):248-53. Increased expression of calpain 6 in uterine sarcomas and carcinosarcomas: an immunohistochemical analysis Lee SJ11, Choi YL, Lee EJ, Kim BG, Bae DS, Ahn GH, Lee JH.
    View PubMed
  • Gynecol Oncol. 2007 Jan;104(1):64-9. Epub 2006 Aug 10. Phase II study of neoadjuvant chemotherapy with mitomycin-c, vincristine and cisplatin (MVC) in patients with stages IB2-IIB cervical carcinoma Choi CH11, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS.
    View PubMed
  • Gynecol Oncol. 2006 Oct;103(1):363-7. Epub 2006 Jun 30. Squamous cell carcinoma with sarcomatoid features of the vulva: A case report and review of literature Choi DS11, Lee JW, Lee SJ, Choi CH, Kim TJ, Lee JH, Bae DS, Ahn G, Kim BG.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2006 Sep-Oct;128(1-2):243-7. Epub 2006 Feb 28. Expression of CD44 adhesion molecules on human placentae Choi CH11, Roh CR, Kim TJ, Choi YL, Lee JW, Kim BG, Lee JH, Bae DS.
    View PubMed
  • Hum Pathol. 2006 Jul;37(7):906-13. Epub 2006 May 26. High expression of tissue inhibitor of metalloproteinase-2 in serous ovarian carcinomas and the role of this expression in ovarian tumorigenesis Kim TJ11, Rho SB, Choi YL, Choi CH, Lee JW, Bae DS, Ahn G, Lee JH, Kim BG.
    View PubMed
  • Int J Gynecol Cancer. 2006 May-Jun;16(3):1157-64. Salvage chemotherapy with a combination of paclitaxel, ifosfamide, and cisplatin for the patients with recurrent carcinoma of the uterine cervix Choi CH11, Kim TJ, Lee SJ, Lee JW, Kim BG, Lee JH, Bae DS.
    View PubMed
  • Oncol Rep. 2006 Mar;15(3):565-9. Germline mutations of BRCA1 in two Korean hereditary breast/ovarian cancer families Kim TJ11, Lee KM, Choi CH, Lee JW, Lee JH, Bae DS, Kim BG.
    View PubMed
  • Int J Gynecol Cancer. 2006 Mar-Apr;16(2):664-9. Analyses of atypical squamous cells refined by the 2001 Bethesda System: the distribution and clinical significance of follow-up management Lee SJ11, Jung KL, Lee JW, Song SY, Kim BG, Lee JH, Park CS, Bae DS.
    View PubMed
  • J Obstet Gynaecol Res. 2006 Feb;32(1):99-106. Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery Lee SJ11, Kim BG, Lee JW, Park CS, Lee JH, Bae DS.
    View PubMed
  • Gynecol Oncol. 2006 Feb;100(2):422-5. Epub 2005 Sep 27. Adenoid cystic carcinoma of the Bartholin's gland: Report of two cases and review of the literature Yang SY11, Lee JW, Kim WS, Jung KL, Lee SJ, Lee JH, Bae DS, Kim BG.
    View PubMed
  • Int J Gynecol Cancer. 2006 Jan-Feb;16(1):95-100. A pilot study of three-cycle consolidation chemotherapy with paclitaxel and platinum in epithelial ovarian cancer patients with clinical complete response after paclitaxel and platinum chemotherapy Lee SJ11, Lee JW, Min JA, Park CS, Kim BG, Lee JH, Bae DS.
    View PubMed
  • Int J Cancer. 2005 Nov 1;117(2):194-201. Increased, expression of ICAM-3 is associated with radiation resistance in cervical cancer Chung YM11, Kim BG, Park CS, Huh SJ, Kim J, Park JK, Cho SM, Kim BS, Kim JS, Yoo YD, Bae DS.
    View PubMed
  • Gynecol Oncol. 2005 Apr;97(1):53-9. Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia Lee JW11, Lee SJ, Seo J, Song SY, Ahn G, Park CS, Lee JH, Kim BG, Bae DS.
    View PubMed
  • Int J Gynecol Cancer. 2005 Jan-Feb;15(1):146-54. Profiling of differentially expressed genes in human uterine leiomyomas Lee EJ11, Kong G, Lee SH, Rho SB, Park CS, Kim BG, Bae DS, Kavanagh JJ, Lee JH.
    View PubMed